MIRATI THERAPEUTICS INC - COM (MRTX)

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COM
Total 13F shares
63,558,869
Share change
+723,510
Total reported value
$4,438,430,260
Put/Call ratio
119%
Price per share
$69.84
Number of holders
234
Value change
+$56,071,596
Number of buys
128
Number of sells
96

Institutional Holders of MIRATI THERAPEUTICS INC - COM (MRTX) as of Q3 2022

As of 30 Sep 2022, MIRATI THERAPEUTICS INC - COM (MRTX) was held by 234 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 63,558,869 shares. The largest 10 holders included Avoro Capital Advisors LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Aviva Holdings Ltd., PERCEPTIVE ADVISORS LLC, BlackRock Inc., FMR LLC, BOXER CAPITAL, LLC, Camber Capital Management LP, and ARMISTICE CAPITAL, LLC. This page lists 234 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.